Lantern Pharma Inc. (LTRN) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
13/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinLTRN / S&P 204.38% / 15.20% |
LoseLTRN / S&P LTRN unavailable / 15.00% |
LoseLTRN / S&P -8.99% / 50.40% |
| 2026-Q10/3 |
LoseLTRN / S&P -54.79% / -4.33% |
LoseLTRN / S&P LTRN unavailable / 11.30% |
LoseLTRN / S&P -21.20% / 27.70% |
| 2025-Q40/3 |
LoseLTRN / S&P -30.34% / 2.65% |
LoseLTRN / S&P LTRN unavailable / 9.00% |
LoseLTRN / S&P -18.65% / 13.40% |
| 2025-Q31/3 |
WinLTRN / S&P 37.66% / 8.12% |
LoseLTRN / S&P LTRN unavailable / 4.61% |
LoseLTRN / S&P -1.69% / 13.45% |
| 2025-Q20/3 |
LoseLTRN / S&P -10.73% / 10.94% |
LoseLTRN / S&P LTRN unavailable / 4.83% |
LoseLTRN / S&P 7.88% / 10.63% |
| 2025-Q12/3 |
WinLTRN / S&P 10.97% / -4.27% |
LoseLTRN / S&P LTRN unavailable / 4.98% |
WinLTRN / S&P 12.88% / 10.57% |
| 2024-Q41/3 |
LoseLTRN / S&P -13.08% / 2.41% |
LoseLTRN / S&P LTRN unavailable / 5.25% |
WinLTRN / S&P 30.41% / 6.15% |
| 2024-Q31/3 |
LoseLTRN / S&P -21.41% / 5.89% |
LoseLTRN / S&P LTRN unavailable / 5.89% |
WinLTRN / S&P 27.14% / 6.11% |
| 2024-Q21/3 |
LoseLTRN / S&P -46.93% / 4.28% |
LoseLTRN / S&P LTRN unavailable / 5.38% |
WinLTRN / S&P 25.00% / 5.12% |
| 2024-Q12/3 |
WinLTRN / S&P 105.61% / 10.56% |
LoseLTRN / S&P LTRN unavailable / 5.71% |
WinLTRN / S&P 26.36% / 5.59% |
| 2023-Q41/3 |
WinLTRN / S&P 25.51% / 11.69% |
LoseLTRN / S&P LTRN unavailable / 6.81% |
LoseLTRN / S&P LTRN unavailable / 7.78% |
| 2023-Q30/3 |
LoseLTRN / S&P -39.54% / -3.27% |
LoseLTRN / S&P LTRN unavailable / 7.52% |
LoseLTRN / S&P LTRN unavailable / -5.03% |
| 2023-Q21/3 |
WinLTRN / S&P 16.77% / 8.74% |
LoseLTRN / S&P LTRN unavailable / 9.50% |
LoseLTRN / S&P LTRN unavailable / -8.57% |
| 2023-Q10/3 |
LoseLTRN / S&P -20.03% / 7.50% |
LoseLTRN / S&P LTRN unavailable / 10.77% |
LoseLTRN / S&P LTRN unavailable / -15.69% |
| 2022-Q41/3 |
WinLTRN / S&P 26.36% / 7.56% |
LoseLTRN / S&P LTRN unavailable / 11.88% |
LoseLTRN / S&P LTRN unavailable / -17.99% |
| 2022-Q30/3 |
LoseLTRN / S&P -16.29% / -4.88% |
LoseLTRN / S&P LTRN unavailable / 13.47% |
LoseLTRN / S&P LTRN unavailable / -1.41% |
| 2022-Q20/3 |
LoseLTRN / S&P -20.14% / -16.10% |
LoseLTRN / S&P LTRN unavailable / 13.71% |
LoseLTRN / S&P LTRN unavailable / 11.04% |
| 2022-Q10/3 |
LoseLTRN / S&P -10.40% / -4.60% |
LoseLTRN / S&P LTRN unavailable / 15.97% |
LoseLTRN / S&P LTRN unavailable / 42.23% |
| 2021-Q40/3 |
LoseLTRN / S&P -28.62% / 11.03% |
LoseLTRN / S&P LTRN unavailable / 15.00% |
LoseLTRN / S&P LTRN unavailable / 96.40% |
| 2021-Q30/3 |
LoseLTRN / S&P -23.42% / 0.58% |
LoseLTRN / S&P LTRN unavailable / 10.77% |
LoseLTRN / S&P LTRN unavailable / 69.42% |
| 2021-Q20/3 |
LoseLTRN / S&P -19.51% / 8.55% |
LoseLTRN / S&P LTRN unavailable / 6.58% |
LoseLTRN / S&P LTRN unavailable / 51.81% |
| 2021-Q10/3 |
LoseLTRN / S&P -5.77% / 6.17% |
LoseLTRN / S&P LTRN unavailable / -1.06% |
LoseLTRN / S&P LTRN unavailable / 7.39% |
| 2020-Q40/3 |
LoseLTRN / S&P 2.18% / 12.15% |
LoseLTRN / S&P LTRN unavailable / -3.72% |
LoseLTRN / S&P LTRN unavailable / -33.42% |
| 2020-Q31/3 |
WinLTRN / S&P 48.35% / 8.93% |
LoseLTRN / S&P LTRN unavailable / -2.04% |
LoseLTRN / S&P LTRN unavailable / -27.10% |
| 2020-Q20/3 |
LoseLTRN / S&P LTRN unavailable / 20.54% |
LoseLTRN / S&P LTRN unavailable / -0.46% |
LoseLTRN / S&P LTRN unavailable / -27.11% |
| 2020-Q10/3 |
LoseLTRN / S&P LTRN unavailable / -19.60% |
LoseLTRN / S&P LTRN unavailable / 3.47% |
LoseLTRN / S&P LTRN unavailable / -14.75% |
| 2019-Q40/3 |
LoseLTRN / S&P LTRN unavailable / 9.07% |
LoseLTRN / S&P LTRN unavailable / 5.36% |
LoseLTRN / S&P LTRN unavailable / 2.99% |
| 2019-Q30/3 |
LoseLTRN / S&P LTRN unavailable / 1.70% |
LoseLTRN / S&P LTRN unavailable / 5.02% |
LoseLTRN / S&P LTRN unavailable / 0.21% |
| 2019-Q20/3 |
LoseLTRN / S&P LTRN unavailable / 4.30% |
LoseLTRN / S&P LTRN unavailable / 6.64% |
LoseLTRN / S&P LTRN unavailable / 8.65% |
| 2019-Q10/3 |
LoseLTRN / S&P LTRN unavailable / 13.65% |
LoseLTRN / S&P LTRN unavailable / 8.12% |
LoseLTRN / S&P LTRN unavailable / 14.29% |
| 2018-Q40/3 |
LoseLTRN / S&P LTRN unavailable / -13.52% |
LoseLTRN / S&P LTRN unavailable / 9.05% |
LoseLTRN / S&P LTRN unavailable / 18.23% |
| 2018-Q30/3 |
LoseLTRN / S&P LTRN unavailable / 7.71% |
LoseLTRN / S&P LTRN unavailable / 10.21% |
LoseLTRN / S&P LTRN unavailable / 19.06% |
| 2018-Q20/3 |
LoseLTRN / S&P LTRN unavailable / 3.43% |
LoseLTRN / S&P LTRN unavailable / 9.03% |
LoseLTRN / S&P LTRN unavailable / 14.46% |
| 2018-Q10/3 |
LoseLTRN / S&P LTRN unavailable / -0.76% |
LoseLTRN / S&P LTRN unavailable / 7.68% |
LoseLTRN / S&P LTRN unavailable / 12.46% |
| 2017-Q40/3 |
LoseLTRN / S&P LTRN unavailable / 6.64% |
LoseLTRN / S&P LTRN unavailable / 7.03% |
LoseLTRN / S&P LTRN unavailable / 13.82% |
| 2017-Q30/3 |
LoseLTRN / S&P LTRN unavailable / 4.48% |
LoseLTRN / S&P LTRN unavailable / 5.68% |
LoseLTRN / S&P LTRN unavailable / 17.57% |
| 2017-Q20/3 |
LoseLTRN / S&P LTRN unavailable / 3.09% |
LoseLTRN / S&P LTRN unavailable / 4.83% |
LoseLTRN / S&P LTRN unavailable / 17.74% |
| 2017-Q10/3 |
LoseLTRN / S&P LTRN unavailable / 6.07% |
LoseLTRN / S&P LTRN unavailable / 3.67% |
LoseLTRN / S&P LTRN unavailable / 13.32% |
| 2016-Q40/3 |
LoseLTRN / S&P LTRN unavailable / 3.82% |
LoseLTRN / S&P LTRN unavailable / 2.09% |
LoseLTRN / S&P LTRN unavailable / 7.05% |
| 2016-Q30/3 |
LoseLTRN / S&P LTRN unavailable / 3.85% |
LoseLTRN / S&P LTRN unavailable / 0.20% |
LoseLTRN / S&P LTRN unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | LTRN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -47.06% | 20.78% |
| Annualized return | -47.06% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | LTRN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -84.39% | 83.14% |
| Annualized return | -31.03% | 12.86% |
10Y · 2020-06-11 to 2026-08-27
| Metric | LTRN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -85.55% | 319.30% |
| Annualized return | -17.59% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |